Core Viewpoint - The company emphasizes the protection of minority investors' interests through various measures, including performance growth, stable dividends, transparent information disclosure, and enhanced investor relations management [2]. Group 1: Performance Growth - The company focuses on its core business and invests in research and development to drive technological breakthroughs and expand its domestic and international operations, thereby unlocking growth potential and enhancing intrinsic value for minority shareholders [2]. Group 2: Dividend Policy - The company has established a sustainable profit distribution policy, committing to at least one profit distribution per year, with cash distributions amounting to no less than 65% of the annual distributable profits. Since its IPO in 2018, the company has not engaged in refinancing and has distributed a total of 37.3 billion yuan in dividends, which is six times the IPO fundraising amount of 5.934 billion yuan [2]. Group 3: Information Disclosure - The company prioritizes the importance of timely and relevant information disclosure, actively sharing information that aids investors' decision-making regarding industry changes, business operations, and risk factors, thereby enhancing market confidence and maintaining the company's image [2]. Group 4: Investor Relations Management - The company has established a comprehensive and efficient investor communication platform, utilizing various online channels and organizing events such as conference calls, performance briefings, and investor visits to foster positive interactions and improve transparency in management [2].
迈瑞医疗:公司高度重视中小投资者的利益保护